Capital Advisors »

Acrivon Therapeutics shares owned by Capital Advisors

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Capital Advisors from 13F filings

Historical chart of Capital Advisors investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $0 48 0.00
2024-06-30 $0 48 0.00
2024-03-31 $0 48 0.00

More positions owned by Capital Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus 1000 Grw Etf (IWF)
Caesars Entertainment (CZR)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Rus 1000 Val Etf (IWD)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Msci Usa Min Vol (USMV)
Spdr Ser Tr S&p Divid Etf (SDY)
Ishares Tr S&p Mc 400gr Etf (IJK)
Ishares Tr Core Div Grwth (DGRO)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr S&p Mc 400vl Etf (IJJ)
Ishares Tr S&p 500 Grwt Etf (IVW)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Capital Advisors

Top funds holding Acrivon Therapeutics

RA Capital Management
Perceptive Advisors
Citadel Advisors
Sands Capital Ventures
Marshall Wace
BlackRock
BlackRock
Vanguard Group
Geode Capital Management
State Street Corporation
Exome Asset Management
Charles Schwab Investment Management
DAFNA Capital Management
Northern Trust
Bridgeway Capital Management

View all funds holding Acrivon Therapeutics